• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PNPLA3基因多态性作为功能获得性突变在非酒精性脂肪性肝病发病机制中的作用。

The effect of PNPLA3 polymorphism as gain in function mutation in the pathogenesis of non-alcoholic fatty liver disease.

作者信息

Delik Anıl, Akkız Hikmet, Dinçer Sadık

机构信息

Department of Gastroenterology, Faculty of Medicine, Çukurova University, 01330, Adana, Turkey.

Department of Biology, Faculty of Natural and Applied Science, Çukurova University, 01330, Adana, Turkey.

出版信息

Indian J Gastroenterol. 2020 Feb;39(1):84-91. doi: 10.1007/s12664-020-01026-x. Epub 2020 Apr 24.

DOI:10.1007/s12664-020-01026-x
PMID:32333362
Abstract

BACKGROUND

Non-alcoholic fatty liver disease (NAFLD) is often associated with metabolic syndrome (type 2 diabetes, hypertension, hypertriglyceridemia, insulin resistance, and obesity). NAFLD is multi-factorial in pathogenesis with some genetic predisposition. The variant patatin-like phospholipase domain-containing protein 3 (PNPLA3) is known to be an independent risk factor for hepatocellular cancer (HCC). The aim of this study was to investigate the role of PNPLA3 polymorphism as the risk factor for NAFLD.

METHODOLOGY

Patients had histological, ultrasonographic, biopsy evidence of NAFLD (n=248) and 81 controls were studied for PNPLA3 polymorphism. PNPLA3 genotyping was done from peripheral blood DNA by real-time polymerase chain reaction (RT-PCR).

RESULTS

PNPLA3 genotyping of the groups NAFLD (CC [n = 76], CG [n = 83], GG [n = 89]) and control (CC [n= 42], CG [n = 22], GG [n = 17]) was determined. In the patient group, the G allele was 261 (52.63%) and the C allele was 235 (47.37%), whereas in the control group, the G allele was 56 (34.54%) and the C allele was 106 (65.43%). In our study, 53 out of 174 women had GG allele and 54 out of 155 men had GG allele.

CONCLUSION

The findings suggest that there is a predominant relationship between men with PNPLA3 I148M variant with NAFLD in women. Patients with NAFLD carrying PNPLA3 rs738409 G>C variant are at higher risk of NAFLD.

摘要

背景

非酒精性脂肪性肝病(NAFLD)常与代谢综合征(2型糖尿病、高血压、高甘油三酯血症、胰岛素抵抗和肥胖)相关。NAFLD发病机制具有多因素性,存在一定的遗传易感性。已知含patatin样磷脂酶结构域蛋白3(PNPLA3)变体是肝细胞癌(HCC)的独立危险因素。本研究旨在探讨PNPLA3基因多态性作为NAFLD危险因素的作用。

方法

对有NAFLD组织学、超声、活检证据的患者(n = 248)和81名对照者进行PNPLA3基因多态性研究。通过实时聚合酶链反应(RT-PCR)从外周血DNA进行PNPLA3基因分型。

结果

确定了NAFLD组(CC [n = 76],CG [n = 83],GG [n = 89])和对照组(CC [n = 42],CG [n = 22],GG [n = 17])的PNPLA3基因分型。在患者组中,G等位基因有261个(52.63%),C等位基因有235个(47.37%),而在对照组中,G等位基因有56个(34.54%),C等位基因有106个(65.43%)。在我们的研究中,174名女性中有53名有GG等位基因,155名男性中有54名有GG等位基因。

结论

研究结果表明,携带PNPLA3 I148M变体的男性与女性NAFLD之间存在显著关系。携带PNPLA3 rs738409 G>C变体的NAFLD患者患NAFLD的风险更高。

相似文献

1
The effect of PNPLA3 polymorphism as gain in function mutation in the pathogenesis of non-alcoholic fatty liver disease.PNPLA3基因多态性作为功能获得性突变在非酒精性脂肪性肝病发病机制中的作用。
Indian J Gastroenterol. 2020 Feb;39(1):84-91. doi: 10.1007/s12664-020-01026-x. Epub 2020 Apr 24.
2
Carriage of the PNPLA3 rs738409 C >G polymorphism confers an increased risk of non-alcoholic fatty liver disease associated hepatocellular carcinoma.载脂蛋白基因 PNPLA3 rs738409C>G 多态性增加非酒精性脂肪性肝病相关肝细胞癌的风险。
J Hepatol. 2014 Jul;61(1):75-81. doi: 10.1016/j.jhep.2014.02.030. Epub 2014 Mar 6.
3
PNPLA3 I148M Polymorphism in Patients with Nonalcoholic Fatty Liver Disease, Obesity and Prediabetes.非酒精性脂肪性肝病、肥胖症和糖尿病前期患者的 PNPLA3 I148M 多态性。
J Gastrointestin Liver Dis. 2019 Dec 9;28(4):433-438. doi: 10.15403/jgld-506.
4
Association of PNPLA3 rs738409 G/C gene polymorphism with nonalcoholic fatty liver disease in children: a meta-analysis.载脂蛋白基因多态性与儿童非酒精性脂肪性肝病的关系: 荟萃分析。
BMC Med Genet. 2020 Aug 18;21(1):163. doi: 10.1186/s12881-020-01098-8.
5
Effect of PNPLA3 polymorphism on diagnostic performance of various noninvasive markers for diagnosing and staging nonalcoholic fatty liver disease.载脂蛋白 PLA3 基因多态性对各种非侵入性标记物诊断和分期非酒精性脂肪性肝病的诊断性能的影响。
J Gastroenterol Hepatol. 2020 Jun;35(6):1057-1064. doi: 10.1111/jgh.14894. Epub 2019 Dec 9.
6
Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.验证 PNPLA3 多态性作为混合人群非酒精性脂肪性肝病和肝纤维化的危险因素。
Ann Hepatol. 2019 May-Jun;18(3):466-471. doi: 10.1016/j.aohep.2018.10.004. Epub 2019 Apr 18.
7
I148M variant of PNPLA3 increases the susceptibility to non-alcoholic fatty liver disease caused by obesity and metabolic disorders.PNPLA3的I148M变体增加了由肥胖和代谢紊乱引起的非酒精性脂肪性肝病的易感性。
Aliment Pharmacol Ther. 2016 Mar;43(5):631-42. doi: 10.1111/apt.13521. Epub 2016 Jan 13.
8
Association of single nucleotide polymorphism at PNPLA3 with fatty liver, steatohepatitis, and cirrhosis of liver.PNPLA3基因单核苷酸多态性与脂肪肝、脂肪性肝炎及肝硬化的关联
Indian J Gastroenterol. 2017 Sep;36(5):366-372. doi: 10.1007/s12664-017-0784-y. Epub 2017 Oct 4.
9
PNPLA3 genotype increases susceptibility of nonalcoholic steatohepatitis among obese patients with nonalcoholic fatty liver disease.PNPLA3基因分型增加了非酒精性脂肪性肝病肥胖患者患非酒精性脂肪性肝炎的易感性。
Surg Obes Relat Dis. 2015 Jul-Aug;11(4):888-94. doi: 10.1016/j.soard.2014.07.016. Epub 2014 Aug 1.
10
Relationship between non-alcoholic steatohepatitis, PNPLA3 I148M genotype and bone mineral density in adolescents.非酒精性脂肪性肝炎、PNPLA3 I148M 基因型与青少年骨密度的关系。
Liver Int. 2018 Dec;38(12):2301-2308. doi: 10.1111/liv.13955. Epub 2018 Sep 25.

引用本文的文献

1
From NAFLD to MASLD: Meta-analysis and systematic review of NAFLD patients in Turkiye in terms of metabolic profile and MASLD potential.从非酒精性脂肪性肝病到代谢功能障碍相关脂肪性肝病:土耳其非酒精性脂肪性肝病患者代谢特征及代谢功能障碍相关脂肪性肝病潜在风险的荟萃分析与系统评价
Hepatol Forum. 2024 Jul 2;5(3):126-138. doi: 10.14744/hf.2023.2023.0042. eCollection 2024.
2
Genetic Predictors of Comorbid Course of COVID-19 and MAFLD: A Comprehensive Analysis.遗传因素预测 COVID-19 和 MAFLD 共病病程:综合分析。
Viruses. 2023 Aug 12;15(8):1724. doi: 10.3390/v15081724.
3
Mitochondrial Mutations and Genetic Factors Determining NAFLD Risk.
线粒体突变与决定非酒精性脂肪性肝病风险的遗传因素
Int J Mol Sci. 2021 Apr 24;22(9):4459. doi: 10.3390/ijms22094459.
4
Function of TREM1 and TREM2 in Liver-Related Diseases.TREM1 和 TREM2 在肝脏相关疾病中的作用。
Cells. 2020 Dec 7;9(12):2626. doi: 10.3390/cells9122626.